(via TheNewswire)

Vancouver, British Columbia – TheNewswire - February 4, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), is pleased to report following its recent success in meeting with mining and health executives in South America, it has deployed a team of software engineers to the mining industry in country. The team deployed will be working with health and mining officials to build a protocol for practical implementation of drug and alcohol screening by voice.  

The voice analytics enterprise solution being developed by MindBio’s engineers is a game changer for intoxication detection in the mining industry, aviation and construction and where high-volume testing at scale for a variety of drugs and alcohol presents major challenges for management and law enforcement, is time consuming, physically invasive and expensive.  

The Company’s CEO Justin Hanka said, “MindBio is seizing its first mover advantage in voice activated AI digital health diagnostics by investing heavily to develop scalable solutions for workplace health and safety related to drug and alcohol intoxication. We are excited by the response we have received and look to provide a solution to the mining industry initially in Chile and then more broadly in South America and globally”.

National work force studies in Chile alone, show that alcohol consumption among mining workers exceeds 75 per cent and the proportion of problem drinkers is above 40 per cent with drug use estimated in 9 per cent of the more than 200,000 mining workers in the country (ACHS, 2012: SENDA, 2024). Internationally more than 20 to 25 per cent of all occupational accidents are directly or indirectly linked to substance use (International Labour Organization 1996, 2022: Gomez et al., 2002). This translates to tens of thousands of preventable workplace incidents related to drug and alcohol intoxication, creating a large potential market for the Company’s Al Platform.

About MindBio Therapeutics Corp

MinBio is a biotechnology company that conducts clinical health research and has developed a world first AI prediction tool for drug and alcohol intoxication detection by a simple analysis of the voice. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The Company is now collecting data that will allow its prediction tool to work on other types of intoxication.

For further information, please contact:

Justin Hanka, Chief Executive Officer

61 433140886

justin@mindbiotherapeutics.com

www.mindbiotherapeutics.com

About MindBio Therapeutics

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is a biotechnology company headquartered in Vancouver, British Columbia, that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning.  The Company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication and has created a world first voice and AI powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations.  The Company is developing a comprehensive enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.

Cautionary Note Concerning Forward-Looking Statements:

The press release contains "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "budget," "believe," "project," "estimate," "expect," "scheduled," "forecast," "strategy," "future," "likely," "may," "to be," "could," "would," "should," "will" and similar references to future periods or the negative or comparable terminology, as well as terms usually used in the future and conditional. Forward-looking statements are based on assumptions as of the date they are provided. However, there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

Additionally, there are known and unknown risk factors that could cause the Company's actual results and financial conditions to differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important risk factors that could cause actual results and financial conditions to differ materially from those indicated in the forward-looking statements, include among others: general economic, market and business conditions in Canada and Australia; market volatility; unforeseen delays in timelines for any of the transactions or events described in this press release.  All forward-looking information is qualified in its entirety by this cautionary statement.

The Company disclaims any obligation to revise or update any such forward-looking statement or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.